GE Healthcare to Pay $30M to Resolve Fraud Allegations on Myoview Dilution
December 28, 2011 by Mercedes Varasteh Dordeski
GE Healthcare, a global provider of medical technologies and pharmaceuticals, has agreed to pay $30M to resolve allegations that it knowingly provided false or misleading information to the federal Medicare program in connection with the distribution of Myoview.
For the full press release, click here.
